Item 5. Other Information
Item
5. Other Information.
None.
21
Item
6. Exhibits
Exhibit No.
Description
31.1
Certification
of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2
Certification
of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
Certification
of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2
Certification
of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS
Inline XBRL Instance Document.
101.SCH
Inline XBRL Taxonomy Extension Schema Document .
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase
Document .
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document .
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase
Document .
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase
Document .
104
Cover Page Interactive Data File (formatted as inline
XBRL and contained in Exhibit 101) .
22
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
PASITHEA THERAPEUTICS CORP.
By:
/s/
Tiago Reis Marques
Tiago Reis Marques
Chief Executive Officer
(Principal Executive Officer)
Date: November
18, 2021
By:
/s/ Stanley
M. Gloss
Stanley M. Gloss
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
Date: November 18, 2021
23
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.